The clinical trial payment process has long been frustrating for sites as well as sponsors and their CROs, with uncertain invoicing procedures, misunderstandings around payment terms and data entry complications often leading to late, incorrect or missed payments. Add to the picture the trend toward increased trial complexity, adoption of new technologies and the use of decentralized trial (DCT) methods, and all parties are feeling the pinch of payment problems more than ever. Read More
There’s considerable buzz around the idea of letting trial participants use their own electronic devices to run trial apps, and the strategy has risen in popularity alongside the decentralized trials (DCT) movement. For sites unfamiliar with BYOD (bring your own device) trials, planning and prepping with the technology in mind is essential to managing this still evolving model successfully. Read More
Only 45 percent of cancer drug trials made their individual participant data (IPD) available to other qualified researchers over the past 10 years, according to a new study. Read More
The European Medicines Agency (EMA) has seen a modest but steady rise in the number of trial applications submitted to its new Clinical Trial Information System (CTIS) since the platform launched on Jan. 31. Read More
With the acquisition of a site in Germany, U.S.-based integrated site organization (ISO) Velocity Clinical Research has made its first strides toward expanding into Europe. Read More
